Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

Sanofi/Regeneron wins another EU approval for Dupixent

Sanofi/Regeneron wins another EU approval for Dupixent the US and Japan.

Astellas stays ahead of its FLT3 rivals with EU nod for Xospata

Astellas stays ahead of its FLT3 rivals with EU nod for Xospata Approval comes after an accelerated review of the drug. Japan’s Astellas Pharma has won EU approval for Xospata, a drug to treat acute myeloid leukaemia associated with a mutation in ... times. Xospata has already been approved for this indication in

AZ reports growth again in Q3, driven by oncology and China sales

AZ reports growth again in Q3, driven by oncology and China sales Another strong performance from our new medicines accompanied impressive results in our key markets, most notably in China, the US and Japan.

Novartis grows in Q3 thanks to stellar performance of key drugs

Novartis grows in Q3 thanks to stellar performance of key drugs The therapy is currently under regulatory review in Europe and Japan, with decisions expected in 2020. ... The FDA in the US is still investigating the data manipulation – Novartis CEO Vas Narasimhan (pictured below) has said however that “for both

Roche scores another FDA approval for Xofluza

Roche scores another FDA approval for Xofluza Roche holds worldwide rights to the drug, excluding Japan and Taiwan, which are retained exclusively by Shionogi.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics